Skip to content

    Recently Viewed

      Listening...

      Innovation

      September 29, 2023
      A doctor holding a catheter for AFib
      September 29, 2023

      5 things we now know about atrial fibrillation

      More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2025, the number of cases will increase by 60%. For World Heart Day, learn the facts behind this heart condition, plus one patient’s diagnosis story.
      Innovation
      Anatomy of the human spine and back
      Innovation

      An eye for innovation: helping surgeons see more during spinal operations

      With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.
      Innovation
      Brain scans may catch Alzheimer's disease before it starts
      Innovation

      Could we be on the cusp of catching Alzheimer’s before it starts?

      The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.
      Innovation
      artificial intelligence in healthcare
      Innovation

      Artificial intelligence is helping revolutionize healthcare as we know it

      Advancing drug discovery. Helping treatments reach patients faster. Diversifying clinical trials. Here’s a look at how Johnson & Johnson is harnessing AI to help create a healthier world.

      Featured stories

      Innovation
      Pipette adding sample to Petri dish for genetic research
      Innovation

      Are super-personalized solutions the future of healthcare?

      The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.
      Innovation
      Researcher using a pipette in the lab
      Innovation

      Behind the relentless pursuit of multiple myeloma cures

      Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.
      Innovation
      scientist-looking-through-microscope
      Innovation

      Advancing new options for bladder cancer treatment

      Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.
      Innovation
      A diverse group of people sitting down on chairs
      Innovation

      What are clinical trials?

      Behind every innovative medicine, treatment and therapy is a clinical trial. Here’s a closer look at how they work.
      Innovation
      Inside-the-Decade-Long-Effort-to-Add-Digital-Tags-to-Thousands-of-Johnson-and-Johnson-MedTech-Products-0423.jpg
      Innovation

      Inside the decade-long effort to add digital tags to thousands of Johnson & Johnson MedTech products

      Efficiently tracking medical devices can cut down on injuries and errors. But until recently, there was no industry-wide standard for doing it. Unique Device Identifiers, a new kind of label, are changing that.

      More from Johnson & Johnson

      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      Health & wellness
      PsaQuizLede.jpeg
      Health & wellness

      Quiz: How much do you know about psoriasis?

      The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. For World Psoriasis Day, take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common autoimmune disease.
      Health & wellness
      What It's Like When Your Baby Has a Rare Blood Disorder-1023.jpg
      Health & wellness

      What it’s like when your baby has a rare blood disorder

      A condition called fetal and neonatal alloimmune thrombocytopenia (FNAIT) can be deadly in newborns. That’s why Johnson & Johnson is passionate about developing a treatment for the disorder.
      You are now leaving JNJ.com and going to a site with a different privacy policy. Please click below to continue to that site.